In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
However, more recent observations from numerous case reports (summarized below) suggest that the risk of permanent injury is relatively low
Febrile reactions, infections, thrombosis, phlebitis, extravasation
Each and every cell in our body has the capability to make glutathione on its own according to its metabolic demands. - Shalin Kochar Why Glutathione Levels May Decline Over Time Glutathione demand appears to increase in response to cumulative physiologic stress
correlation over a short, attention-heavy window is exactly the setup in which unrelated changes get misattributed
So that's the part that I want everybody to understand
